DE69326400T2 - Verfahren zur Herstellung von Cephalosporin Zwischenverbindungen - Google Patents

Verfahren zur Herstellung von Cephalosporin Zwischenverbindungen

Info

Publication number
DE69326400T2
DE69326400T2 DE69326400T DE69326400T DE69326400T2 DE 69326400 T2 DE69326400 T2 DE 69326400T2 DE 69326400 T DE69326400 T DE 69326400T DE 69326400 T DE69326400 T DE 69326400T DE 69326400 T2 DE69326400 T2 DE 69326400T2
Authority
DE
Germany
Prior art keywords
compound
formula
mmol
added
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69326400T
Other languages
German (de)
English (en)
Other versions
DE69326400D1 (de
Inventor
Gary M.F. Lim
John M. Roubie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE69326400D1 publication Critical patent/DE69326400D1/de
Application granted granted Critical
Publication of DE69326400T2 publication Critical patent/DE69326400T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cephalosporin Compounds (AREA)
DE69326400T 1992-07-24 1993-07-23 Verfahren zur Herstellung von Cephalosporin Zwischenverbindungen Expired - Lifetime DE69326400T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92023292A 1992-07-24 1992-07-24

Publications (2)

Publication Number Publication Date
DE69326400D1 DE69326400D1 (de) 1999-10-21
DE69326400T2 true DE69326400T2 (de) 2000-05-18

Family

ID=25443394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326400T Expired - Lifetime DE69326400T2 (de) 1992-07-24 1993-07-23 Verfahren zur Herstellung von Cephalosporin Zwischenverbindungen

Country Status (14)

Country Link
US (1) US5594131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0581220B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3406653B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100290519B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE184608T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2099692C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69326400T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0581220T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2137211T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3032045T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU213399B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106388A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9304433A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW232695B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN184516B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1996-01-19 2000-09-02 Lupin Laoratories Ltd
AU2307297A (en) * 1996-04-12 1997-11-07 Takeda Chemical Industries Ltd. Production of 7-aminocephalosporanic acid derivative
JP4616844B2 (ja) * 2003-12-23 2011-01-19 サンド・ゲーエムベーハー セファロスポリン合成に使用するための中間体の生成プロセス
US20070111980A1 (en) 2004-07-16 2007-05-17 Bandi Parthasaradhi Reddy Process for preparing pure cephalosporine intermediates
WO2006075244A2 (en) * 2005-01-17 2006-07-20 Orchid Chemicals & Pharmaceuticals Ltd Improved process for the preparation of cephalosporin antibiotic intermediate
WO2008010042A2 (en) * 2006-07-18 2008-01-24 Orchid Chemicals & Pharmaceuticals Limited Improved process for the preparation of cefepime intermediate
WO2009004463A1 (en) * 2007-07-04 2009-01-08 Orchid Chemicals & Pharmaceuticals Limited Improved process for the preparation of cefepime intermediate
CN107201391B (zh) * 2017-07-04 2020-07-07 吉林省爱诺德生物工程有限公司 一种盐酸头孢吡肟的合成方法
EP4019118A1 (en) * 2020-12-28 2022-06-29 Sartorius Stedim Biotech GmbH Method and system for testing the integrity of filters

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4574052A (en) * 1984-05-31 1986-03-04 Richardson-Vicks Inc. Crackling aerosol foam
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4659812A (en) 1985-08-20 1987-04-21 Bristol-Myers Company Cephalosporin intermediates
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates

Also Published As

Publication number Publication date
DE69326400D1 (de) 1999-10-21
IL106388A0 (en) 1993-11-15
CA2099692C (en) 2003-09-30
MX9304433A (es) 1994-02-28
KR100290519B1 (ko) 2001-09-17
KR940002257A (ko) 1994-02-17
CA2099692A1 (en) 1994-01-25
ATE184608T1 (de) 1999-10-15
EP0581220A3 (en) 1994-05-18
EP0581220B1 (en) 1999-09-15
DK0581220T3 (da) 1999-12-20
TW232695B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-10-21
GR3032045T3 (en) 2000-03-31
EP0581220A2 (en) 1994-02-02
ES2137211T3 (es) 1999-12-16
JPH06184161A (ja) 1994-07-05
HUT64963A (en) 1994-03-28
IL106388A (en) 1999-10-28
US5594131A (en) 1997-01-14
HU9302145D0 (en) 1993-10-28
JP3406653B2 (ja) 2003-05-12
HU213399B (en) 1997-06-30

Similar Documents

Publication Publication Date Title
DE2462736C2 (de) 7-Aminothiazolylacetamido-3-cephem-4-carbonsäuren und Verfahren zur Herstellung derselben
DE69431691T2 (de) Cephalosporin-Derivate
DE69634581T2 (de) Antibakterielle Cephalosporine
DE69326400T2 (de) Verfahren zur Herstellung von Cephalosporin Zwischenverbindungen
EP0081674B1 (de) Zwischenprodukte, Verfahren zu deren Herstellung und Verfahren zur Herstellung von Cephalosporinen
DE1795188B2 (de) 3-Alkoxymethylcephalosporine, Verfahren zu deren Herstellung und die diese enthaltenden pharmazeutischen Zusammensetzungen
DE2936434A1 (de) Cephemverbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische mittel sowie ihre therapeutische verwendung fuer die behandlung von infektionserkrankungen bei menschen und tieren
DE69937143T2 (de) Verfahren zur reinigung eines cephalosporin-derivats
AT392072B (de) Verfahren zur herstellung der neuen 7-amino-3propenylcephalosporansaeure sowie von estern und salzen derselben
DE69803909T2 (de) Verfahren und Zwischenprodukte, die für die Herstellung von Antifolaten verwendbar sind
DE69232216T2 (de) Verfahren zur Herstellung eines antibiotischen Cephalosporin
DE3216256C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69233042T2 (de) Herstellung eines Cephalosporin-Antibiotikums unter Verwendung des Syn-Isomers einer Thiazolylzwischenverbindung
DE3783270T2 (de) 4 halogen-2-oxyimino-3-oxo-buttersaeure.
DE69331576T2 (de) Cephem-verbindungen, verfarhren zu ihrer herstellung und diese enthaltende medikamente
DE69109913T2 (de) Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte.
DE2505280A1 (de) Azetidinderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von cephalosporansaeurederivaten
DE69232776T2 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
DE69521378T2 (de) Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel
DE68921306T2 (de) Verfahren zur Herstellung von 4-Acyloxy-2-azetidinon-Derivaten.
DE69502982T2 (de) Herstellung geschützter Aminothiazolylessigsäurederivate
DE3688067T2 (de) Herstellungsverfahren von cephalosporin-zwischenprodukten.
DE69520554T2 (de) Verfahren zur herstellung von indolocarbazol-derivaten
DE69030399T2 (de) Verfahren zur Herstellung von 3-Exomethylencephamsulfoxydderivate und Zwischenverbindungen
DE3534857A1 (de) Cephalosporinsulfoxide, verfahren zu deren herstellung und deren verwendung bei der herstellung von cephalosporinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition